MarketPeel
Insider Trading Intelligence
Pricing
…
ML

Medicxi Ventures Management (jersey) Ltd

CNTA
10% OWNER · CENTESSA PHARMACEUTICALS PLC · CIK 0001715579
FILING MIX · LIFETIME59%/41%
BUYS
20
SELLS
14
TOTAL VALUE
$24.37M
COMPANIES
2
ACTIVE SINCE
Jun 2021
HOLDINGS NOW
0
AVG SELL PX
—
TRADE KIND
SHOWING 34 / 34
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
14 backtested trades · 8 horizonsHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Medicxi Ventures Management (jersey) Ltd, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d14+57.14%+1.93%+1.14%+0.78%+0.46%—
14d14+42.86%+3.26%+1.88%+1.38%-3.53%—
30d14+42.86%-2.12%+3.56%-5.68%-5.74%—
60d14+0.00%-18.54%-0.80%-17.74%-18.71%—
90d14+14.29%-18.82%-2.64%-16.18%-19.97%—
180d14+14.29%-53.08%-6.63%-46.45%-55.59%—
1y14+0.00%-64.35%-9.81%-54.54%-57.09%—
2y14+0.00%-51.09%+2.28%-53.37%-50.95%—
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
CNTA · 0 shares · as of Jun 24, 2026
02,799,3265,598,6528,397,97711,197,30320222023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 20 buys / 14 sellsCOVERAGE · 21 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
CNTA
CENTESSA PHARMACEUTICALS PLC
SALE
3,936,970——0Jun 24, 2026Jun 24, 2026 ↗View →
CNTA
CENTESSA PHARMACEUTICALS PLC
SALE
4,398,519——0Jun 24, 2026Jun 24, 2026 ↗View →
CNTA
CENTESSA PHARMACEUTICALS PLC
SALE
11,197,303——0Jun 24, 2026Jun 24, 2026 ↗View →
CNTA
CENTESSA PHARMACEUTICALS PLC
SALE
55,677——0Jun 24, 2026Jun 24, 2026 ↗View →
CNTA
CENTESSA PHARMACEUTICALS PLC
SALE
281,162——0Jun 24, 2026Jun 24, 2026 ↗View →
CNTA
CENTESSA PHARMACEUTICALS PLC
SALE
93,526——0Jun 24, 2026Jun 24, 2026 ↗View →
CNTA
CENTESSA PHARMACEUTICALS PLC
PURCHASE
45,054——281,162Mar 21, 2022Mar 23, 2022 ↗View →
CNTA
CENTESSA PHARMACEUTICALS PLC
PURCHASE
1,794,211——11,197,303Mar 21, 2022Mar 23, 2022 ↗View →
CNTA
CENTESSA PHARMACEUTICALS PLC
PURCHASE
796$12.82$10.2K93,526Dec 2, 2021Dec 6, 2021 ↗View →
CNTA
CENTESSA PHARMACEUTICALS PLC
PURCHASE
33,530$12.82$429.9K3,936,970Dec 2, 2021Dec 6, 2021 ↗View →
CNTA
CENTESSA PHARMACEUTICALS PLC
PURCHASE
1,399$12.62$17.7K92,730Dec 1, 2021Dec 2, 2021 ↗View →
CNTA
CENTESSA PHARMACEUTICALS PLC
PURCHASE
58,905$12.62$743.4K3,903,440Dec 1, 2021Dec 2, 2021 ↗View →
CNTA
CENTESSA PHARMACEUTICALS PLC
PURCHASE
855$11.62$9.9K91,331Nov 30, 2021Dec 2, 2021 ↗View →
CNTA
CENTESSA PHARMACEUTICALS PLC
PURCHASE
35,992$11.62$418.2K3,844,535Nov 30, 2021Dec 2, 2021 ↗View →
CNTA
CENTESSA PHARMACEUTICALS PLC
PURCHASE
55,391$11.70$648.1K3,808,543Nov 29, 2021Nov 30, 2021 ↗View →
CNTA
CENTESSA PHARMACEUTICALS PLC
PURCHASE
1,315$11.70$15.4K90,476Nov 29, 2021Nov 30, 2021 ↗View →
CNTA
CENTESSA PHARMACEUTICALS PLC
PURCHASE
11,543$11.34$130.8K3,753,152Nov 26, 2021Nov 30, 2021 ↗View →
CNTA
CENTESSA PHARMACEUTICALS PLC
PURCHASE
274$11.34$3.1K89,161Nov 26, 2021Nov 30, 2021 ↗View →
AURA
AURA BIOSCIENCES, INC.
PURCHASE
54,065——54,065Nov 2, 2021Nov 4, 2021 ↗View →
AURA
AURA BIOSCIENCES, INC.
SALE
5,975——0Nov 2, 2021Nov 4, 2021 ↗View →
AURA
AURA BIOSCIENCES, INC.
SALE
8,876——0Nov 2, 2021Nov 4, 2021 ↗View →
AURA
AURA BIOSCIENCES, INC.
PURCHASE
693,525$14.00$9.71M2,969,352Nov 2, 2021Nov 4, 2021 ↗View →
AURA
AURA BIOSCIENCES, INC.
PURCHASE
2,275,827——2,275,827Nov 2, 2021Nov 4, 2021 ↗View →
AURA
AURA BIOSCIENCES, INC.
SALE
373,606——0Nov 2, 2021Nov 4, 2021 ↗View →
AURA
AURA BIOSCIENCES, INC.
SALE
1,650,676——0Nov 2, 2021Nov 4, 2021 ↗View →
AURA
AURA BIOSCIENCES, INC.
PURCHASE
16,475$14.00$230.7K70,540Nov 2, 2021Nov 4, 2021 ↗View →
AURA
AURA BIOSCIENCES, INC.
SALE
251,545——0Nov 2, 2021Nov 4, 2021 ↗View →
AURA
AURA BIOSCIENCES, INC.
SALE
39,214——0Nov 2, 2021Nov 4, 2021 ↗View →
CNTA
CENTESSA PHARMACEUTICALS PLC
PURCHASE
13,923$20.00$278.5K88,887Jun 2, 2021Jun 4, 2021 ↗View →
CNTA
CENTESSA PHARMACEUTICALS PLC
PURCHASE
586,077$20.00$11.72M3,741,609Jun 2, 2021Jun 4, 2021 ↗View →
CNTA
CENTESSA PHARMACEUTICALS PLC
PURCHASE
44,828——74,964Jun 2, 2021Jun 4, 2021 ↗View →
CNTA
CENTESSA PHARMACEUTICALS PLC
PURCHASE
1,886,990——3,155,532Jun 2, 2021Jun 4, 2021 ↗View →
CNTA
CENTESSA PHARMACEUTICALS PLC
SALE
44,828——0Jun 2, 2021Jun 4, 2021 ↗View →
CNTA
CENTESSA PHARMACEUTICALS PLC
SALE
1,886,990——0Jun 2, 2021Jun 4, 2021 ↗View →
Other insiders · CNTA
Loading peer insiders…
About this filer
CIK 0001715579
ROLE
10% Owner
PRIMARY
CNTA
COMPANIES
2
ACTIVE SINCE
Jun 2021
MARKETPEEL · /INSIDER/0001715579DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback